Solasto Corp

6197
stockHealthcareHealth Care ServicesTokyo, Japan
$6/day into 6197 since 2016 would be worth $25,493 today — 1.7× the money.
Try your own number →

Solasto Corporation provides medical outsourcing services to medical institutions in Japan. It operates through the Medical Business, Nursing Care Business, Children's Business, and Others segments. The Medical Business segment offers medical administration, medical affairs, and hospital management support services, as well as various surveys and analyses in the fields of medical administration and hospital management, document preparation, lectures and training, and educational courses on medical administration services. Its Nursing Care Business segment provides nursing care services, including nursing homes, residential nursing homes, and serviced housing for the elderly, as well as day care and home help services. The Children's Business segment offers childcare services, such as licensed, certified, and small-scale childcare centers, as well as childcare centers for recovering children. Its Others segment operates its smart hospital business that provides remote medical fee billing services to medical institutions. Solasto Corporation was formerly known as N.I.C Corporation. The company was founded in 1965 and is headquartered in Tokyo, Japan. As of May 11, 2026, Solasto Corporation operates as a subsidiary of MP-2605 Co., Ltd.

Description from Yahoo Finance
Full profile on Yahoo Finance →

If you'd bought from year…

Same habit, different start year. Each row shows what a constant habit's worth of 6197-T would be worth today, had you started buying at that point in the asset's history.

Started$6/day$6/day coffee$42/wk$42/week coffee
Year 1 (2016) — listing
$25,493
1.7×
$37,835
1.7×
Year 6 (2021)
$13,877
1.8×
$20,726
1.7×

Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.

Headquarters

Tokyo, Japan

Popular scenarios with 6197

solasto.co.jp

For illustration only — not investment advice. Past performance is not indicative of future results.